According to the announcement on 27 April.
Launch preparations for BREVAGen are nearing completion and the Company expects to offer the test to US physicians and their patients in coming weeks.?
BREVAGen will be made available to European and PacRim markets following further regulatory and market development programs.
- Forums
- ASX - By Stock
- GTG
- more news to come
more news to come
Featured News
Add GTG (ASX) to my watchlist
|
|||||
Last
6.3¢ |
Change
-0.005(7.35%) |
Mkt cap ! $8.329M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.2¢ | $17.61K | 272.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4447 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4447 | 0.062 |
1 | 34375 | 0.061 |
4 | 35220 | 0.060 |
1 | 35590 | 0.059 |
1 | 80000 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 10000 | 1 |
0.068 | 12247 | 1 |
0.077 | 6741 | 2 |
0.078 | 74763 | 3 |
0.080 | 50000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |